
Quotient Limited QTNT
Quartalsbericht 2023-Q3
hinzugefügt 23.05.2026
Quotient Limited EV 2011-2026 | QTNT
EV Jährlich Quotient Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 273 M | 447 M | 767 M | 694 M | 368 M | 269 M | 124 M | 281 M | 26.8 M | 31.7 M | 31 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 767 M | 26.8 M | 301 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 136.96 | 1.16 % | $ 41.6 B | ||
|
Celcuity
CELC
|
5.57 B | $ 133.65 | 2.09 % | $ 6.25 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 8.7 | -22.27 % | $ 11.6 M | ||
|
Castle Biosciences
CSTL
|
463 M | $ 21.25 | -3.89 % | $ 616 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
583 M | $ 18.59 | 1.92 % | $ 572 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
15.2 B | $ 128.73 | -3.37 % | $ 16.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 22.9 | 0.88 % | $ 1.22 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
16.5 B | $ 137.9 | 0.8 % | $ 10.8 B | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.7 | -5.56 % | $ 7.52 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 164.95 | 3.94 % | $ 26.2 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 100.51 | 0.89 % | $ 6.78 B | ||
|
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 179.61 | 1.38 % | $ 24.3 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 184.52 | 1.75 % | $ 9.15 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 10.61 | 4.07 % | $ 1.36 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
National Research Corporation
NRC
|
432 M | $ 19.96 | 1.53 % | $ 447 M | ||
|
Natera
NTRA
|
5.53 B | $ 221.45 | 3.51 % | $ 21.8 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 451.97 | 0.86 % | $ 13 B | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.01 | -5.09 % | $ 371 M | ||
|
Personalis
PSNL
|
380 M | $ 11.58 | 5.46 % | $ 1.03 B | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.56 | 0.4 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.73 | 0.15 % | $ 281 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 70.01 | 1.42 % | $ 4.19 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.38 | -2.26 % | $ 5.47 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 262.26 | 0.09 % | $ 21.8 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 496.58 | 1.93 % | $ 187 B | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.72 | 1.73 % | $ 259 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.22 | -0.86 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 195.52 | -0.4 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M |